Raphael Pharmaceutical (RAPH) Change in Cash (2020 - 2025)
Raphael Pharmaceutical's (RAPH) quarterly Change in Cash came in at $42000.0 in Q4 2025, up 300.0% year-over-year from $10500.0 in Q4 2024, and up 347.06% quarter-over-quarter from -$17000.0 in Q3 2025.
Powered by 
Analysis
Raphael Pharmaceutical (RAPH) Change in Cash (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has disclosed Change in Cash across 6 years of filings, most recently posting $42000.0 for Q4 2025.
- In Q4 2025, Change in Cash rose 300.0% year-over-year to $42000.0; the TTM figure through Dec 2025 stood at $26000.0 (up 112.32% YoY), while the FY2025 annual figure was $26000.0, up 112.32% from the prior year.
- Change in Cash came in at $42000.0 for Q4 2025 at Raphael Pharmaceutical, up from -$17000.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $208000.0 in Q2 2021 to a low of -$250000.0 in Q1 2023.
- Average Change in Cash over 5 years is -$2500.0, with a median of -$19000.0 recorded in 2024.
- Year-over-year, Change in Cash soared 547.62% in 2023 and sank 328.77% in 2024.
- Over 5 years, Change in Cash stood at $116000.0 in 2021, then jumped by 68.1% to $195000.0 in 2022, then plunged by 135.38% to -$69000.0 in 2023, then jumped by 69.57% to -$21000.0 in 2024, then surged by 300.0% to $42000.0 in 2025.
- Per Business Quant data, the three most recent Change in Cash figures were $42000.0 in Q4 2025, -$17000.0 in Q3 2025, and -$30000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -4.45 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 649.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | -504.60 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -185.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -170.44 Mn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | -17,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | -21,000.00 |
| Sep 30, 2024 | -80,000.00 |
| Jun 30, 2024 | -167,000.00 |
| Mar 31, 2024 | 57,000.00 |
| Dec 31, 2023 | -69,000.00 |
| Sep 30, 2023 | 188,000.00 |
| Jun 30, 2023 | 73,000.00 |
| Mar 31, 2023 | -250,000.00 |
| Dec 31, 2022 | 195,000.00 |
| Sep 30, 2022 | -42,000.00 |
| Jun 30, 2022 | 54,000.00 |
| Mar 31, 2022 | -72,000.00 |
| Dec 31, 2021 | 116,000.00 |
| Sep 30, 2021 | -181,000.00 |
| Jun 30, 2021 | 208,000.00 |
| Mar 31, 2021 | -85,000.00 |